M. Stephens

Ethical Issues in Drug Safety

M. Stephens, 2005 .

The Dawn of Drug Safety

M. Stephens, 2010 .

Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy

R. Mann, L. Wilton, M. Stephens, 1999, Pharmacoepidemiology and Drug Safety.

From Causality Assessment to Product Labeling

M. Stephens, 1997 .

Visual field defect associated with vigabatrin: observational cohort study

R. Mann, L. Wilton, R. Mann, 1999, BMJ.